Neurocrine Biosciences (NBIX) Tops Q4 EPS by 30c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $145.35 -0.51%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
LTBR, AES, SYRS, More
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q4 EPS of $1.05, $0.30 better than the analyst estimate of $0.75. Revenue for the quarter came in at $244.1 million versus the consensus estimate of $230.94 million.
Full-Year 2020 Financial Guidance | |||||||||||||||
Range | |||||||||||||||
(in millions) | Low | High | |||||||||||||
Combined GAAP R&D and SG&A expenses | $ | 740 | $ | 770 | |||||||||||
Combined Non-GAAP R&D and SG&A expenses | $ | 620 | $ | 650 | |||||||||||
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Neurocrine Biosciences (NBIX) Tops Q3 EPS by 138c
- Waystar Holding Corp. (WAY) Reports Q3 EPS of $0.44
- National Presto Indust. (NPK) Reports Q3 EPS of $2.79
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
